首页> 外文会议>Workshop on the utilization of research reactors >Optimization of Hydroxyapatite Particles labeling with Samarium-153 as a Therapeutic Agent for Radiation Synovectomy
【24h】

Optimization of Hydroxyapatite Particles labeling with Samarium-153 as a Therapeutic Agent for Radiation Synovectomy

机译:mar153作为放射滑膜切除术治疗剂的羟基磷灰石颗粒标记的优化

获取原文

摘要

Hydroxyapatite (HA) was studied as a particulate carrier for beta-emitting radionuclides in radiation synovectomy. Particles were labeled with ~(153)Sm (T_(1/2) = 1.95 days, beta-energy = 810 (20percent), 710 (50percent), 640 (30percent) keV, gamma-energy = 103.2 (29.8percent) keV, range of beta particles in tissue is 2.5 mm). Labeling efficiency was greater than 95percent at pH 4-6. The compound is sterile and pyrogen free with its stability of 6 days. In vivo studies by intra-articular injection into the knee joints of normal rats showed the total cumulative leakage of ~(153)Sm over 6 days was around 2 percentage injected dose (ID). The ease of preparation of ~(153)Sm-HA, the high efficiency of labeling and low leakage from the joint make ~(153)Sm-HA attractive for radiation synovectomy.
机译:研究了羟基磷灰石(HA)作为放射滑膜切除术中β发射放射性核素的颗粒载体。用〜(153)Sm(T_(1/2)= 1.95天,β-能量= 810(20%),710(50%),640(30%)keV,γ-能量= 103.2(29.8%)keV标记颗粒,组织中β粒子的范围是2.5毫米)。在pH 4-6时,标记效率大于95%。该化合物是无菌的且无热原,其稳定性为6天。通过关节内注射到正常大鼠的膝关节进行的体内研究显示,在6天内〜(153)Sm的总累积泄漏量约为2%注射剂量(ID)。 〜(153)Sm-HA的易于制备,标记的高效率和从关节的低渗漏使〜(153)Sm-HA对放射滑膜切除术具有吸引力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号